Literature DB >> 15953799

The role of immune system parameters in the relationship between depression and coronary artery disease.

Willem J Kop1, John S Gottdiener.   

Abstract

The relationship between depressive symptoms and coronary artery disease (CAD) is mediated in part by immune system parameters. This review describes research on the psychoneuroimmunological pathways accounting for the association between depression and CAD, and addresses conceptual and methodological issues. Relationships between central nervous system correlates of depression and immune system parameters are bidirectional and are mediated via neurohormonal and parasympathetic pathways. Evidence suggests that these associations can be affected by a) the clinical characteristics of depression (e.g., typical depression versus atypical depression and exhaustion), b) the duration and severity of depressive symptoms, and c) the stage of underlying CAD. Depressive symptoms are hypothesized to affect primarily the transition from stable CAD to acute coronary syndromes via plaque activation and prothrombotic processes, and may play an additional role in the response to injury at early stages of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953799     DOI: 10.1097/01.psy.0000162256.18710.4a

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  37 in total

1.  Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Authors:  Karina W Davidson; Matthew M Burg; Ian M Kronish; Daichi Shimbo; Lucia Dettenborn; Roxana Mehran; David Vorchheimer; Lynn Clemow; Joseph E Schwartz; Francois Lespérance; Nina Rieckmann
Journal:  Arch Gen Psychiatry       Date:  2010-05

2.  Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression.

Authors:  Ali A Weinstein; Patricia A Deuster; Jennifer L Francis; Robert W Bonsall; Russell P Tracy; Willem J Kop
Journal:  Biol Psychol       Date:  2010-01-29       Impact factor: 3.251

3.  [Primary prevention-psychosocial aspects].

Authors:  C Albus; J Siegrist
Journal:  Z Kardiol       Date:  2005

Review 4.  Depression, Anxiety, and Cognitive Impairment : Comorbid Mental Health Disorders in Heart Failure.

Authors:  Christiane E Angermann; Georg Ertl
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 5.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

6.  Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease?

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Psychosom Med       Date:  2012-01-03       Impact factor: 4.312

7.  Expert Opinion-Depression in Patients with Heart Failure: Is Enough Being Done?

Authors:  Amam Mbakwem; Francis Aina; Casmir Amadi
Journal:  Card Fail Rev       Date:  2016-11

Review 8.  Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.

Authors:  James K Rustad; Theodore A Stern; Kathy A Hebert; Dominique L Musselman
Journal:  Prim Care Companion CNS Disord       Date:  2013-08-15

9.  Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study.

Authors:  Shaoyong Su; Andrew H Miller; Harold Snieder; J Douglas Bremner; James Ritchie; Carisa Maisano; Linda Jones; Nancy V Murrah; Jack Goldberg; Viola Vaccarino
Journal:  Psychosom Med       Date:  2008-12-10       Impact factor: 4.312

10.  Interactive effects of race and depressive symptoms on calcification in African American and white women.

Authors:  Tené T Lewis; Susan A Everson-Rose; Alicia Colvin; Karen Matthews; Joyce T Bromberger; Kim Sutton-Tyrrell
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.